Bats suffer from viral infections just as severely as rodents do, according to an extensive new synthesis published this autumn in PLOS Biology. Researchers analyzed 86 years of experimental infection data and found that the occurrence of overt disease, the likelihood of mortality, and the severity of disease in bats are indistinguishable from those in rodents. This challenges long-held assumptions that bats possess unique antiviral traits allowing them to coexist with pathogens without falling ill.
For decades, scientists observed that bats often harbor zoonotic pathogens without displaying obvious signs of sickness. This led to the widespread belief that bat immune systems have unusual antiviral traits, potentially sparked by the metabolic demands of flight. Researchers hoped these mechanisms might translate into broad-spectrum antivirals for humans. However, formal assessments comparing viral outcomes across host groups had been missing until now.
In Plain English: The Clinical Takeaway
- Immune System Realities: Bats do not possess all-encompassing defenses that protect them from every virus. Their immune systems appear to have evolved through conventional evolutionary processes.
- Experimental Consistency: When researchers inoculated bats and rodents with various viruses under controlled conditions, both animal groups experienced similar levels of disease severity and mortality.
-
Translational Research Impact: While studying bat immunology still offers valuable scientific insights, researchers must temper expectations regarding finding broad-acting antiviral drugs directly inspired by bat physiology.
Eighty-Six Years of Experimental Infection Data
To test whether bats truly experience dampened disease symptoms, a research team including Maxwell J. Farrell, Samantha K. Tucker, Nardus Mollentze, and Daniel G. Streicker synthesized data from 112 studies published between 1936 and 2022. The study spans 54 viruses, 15 viral families, 85 host species, and over 5,600 individual animals.
The analysis evaluated compatible host-virus pairs where original investigators confirmed host susceptibility. Researchers tested whether generalized antiviral mechanisms allow bats to reduce disease severity regardless of evolutionary history, or if bats suppress disease from co-evolved viruses more effectively than other mammals due to unique life-history constraints.
The results showed no significant advantage for bats. Disease outcomes were ultimately shaped by experimental design choices, viral host range, and evolutionary context, rather than intrinsic immune superiority.
| Study Parameters | Bat Inoculations | Rodent Inoculations |
|---|---|---|
| Host Species Represented | Across 85 host species | Other mammals |
| Viruses Analyzed | 54 viruses (53 RNA, 1 DNA) | 54 viruses (53 RNA, 1 DNA) |
| Historical Span | 1936 to 2022 | 1936 to 2022 |
| Observed Disease Severity | Indistinguishable from rodents | Indistinguishable from bats |
Evaluating the Broader Biomedical Landscape
The findings do not entirely close the door on pharmaceutical innovation. Researchers emphasize that uncovering molecular pathways still holds considerable scientific value for understanding mammalian immunology.
At the same time, the study does not support the premise that bats will be an unusually rich source of future biomedical breakthroughs. The data indicate that bat immune systems were shaped by standard co-evolutionary pressures rather than anomalous biological circumstances granting exceptional antiviral defenses.
Funding for the underlying research was provided by a Philip Leverhulme Prize in Biological Sciences, a Wellcome Trust Senior Research Fellowship, the NSF/BBSRC Ecology and Evolution of Infectious Diseases Program, an NSERC Postdoctoral Fellowship, the Wellcome Trust Integrative Infection Biology PhD Programme at the University of Glasgow, and core support from the UK Medical Research Council to the MRC-University of Glasgow Centre for Virus Research.
Contraindications & When to Consult a Doctor
Because these findings center on foundational wildlife virology and experimental animal models rather than direct human clinical treatments, there are no immediate medical contraindications for patients. Individuals handling wildlife or working in veterinary fields should continue to adhere to established public health guidelines regarding potential zoonotic exposures.
Future Directions in Zoonotic Research
The work underscores the necessity of evaluating the functional properties of putatively unique bat immune features directly in vivo. As public health agencies and researchers monitor emerging pathogens, distinguishing between anecdotal field observations and rigorous experimental data remains vital.
References
- Farrell, M. G. (2026). Viral disease outcomes are indistinguishable between experimentally infected bats and rodents., 24(10), e3004053.
- Farrell, M. G. (2026). Viral disease outcomes are indistinguishable between experimentally infected bats and rodents..
Disclaimer: This article is for informational purposes only and does not constitute formal medical, veterinary, or epidemiological advice. Always consult local public health authorities or licensed medical professionals for guidance on infectious disease risks.
Worth a look
